SEC Form 4 · accession 0001683168-17-002053
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Umscheid
Officer — Chief Strategy/Mkt Officer
Period of report
Aug 10, 2017
Accepted (ET)
Aug 11, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Aug 10, 2017 | P | 600 | $5.31 | A | 3,392 | D |
Table II — derivative securities
No Table II lines on this filing.